Keros Therapeutics director Charles W. Newton sells 551 common shares worth $5,675.3
KROS•Director share sale
- Keros Therapeutics director Charles W. Newton sold 551 shares of common stock on Aug. 18, 2026.
- The sale was priced at USD 10.3 per share on a weighted-average basis.
- Direct holdings fell to 12,114 shares following the transaction.
